Spinal muscular atrophy type 3 and treatment adherence in a changing therapeutic landscape: a national-center experience
{{output}}
Aim: To report on treatment outcomes in adult patients with spinal muscular atrophy type 3 (SMA3) who had their nusinersen treatment initiated in adulthood. Metho... ...
